Cellectis S.A.
CLLS· Nasdaq
CLLSCellectis S.A.
Source filing unavailable
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $178.00K | $1.35M | $11.18M | $2.90M |
| Net Income | -$11.37M | -$18.95M | -$39.92M | -$32.26M |
| EPS Diluted | -$0.20 | -$0.42 | -$0.88 | -$0.76 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cellectis S.A. · CIK 1627281 · Engraved from SEC EDGAR
